As filed with the Securities and Exchange Commission on July 29, 2024
Registration No. 333-279282
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-8
REGISTRATION STATEMENT (Registration No. 333-279282)
UNDER
THE SECURITIES ACT OF 1933
Silvaco Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 27-1503712 | ||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | ||||
Silvaco Group, Inc.
4701 Patrick Henry Drive
Building #23
Santa Clara, California, 95054
(Address of Principal Executive Offices) (Zip Code)
Amended and Restated 2014 Stock Incentive Plan
2024 Stock Incentive Plan
2024 Employee Stock Purchase Plan
(Full title of the plan)
Dr. Babak A. Taheri
Chief Executive Officer
Silvaco Group, Inc.
4701 Patrick Henry Drive
Building #23
Santa Clara, CA 95054
(408) 567-1000
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)
Copies to:
Drew M. Valentine
Gurpreet Bal
DLA Piper LLP (US)
303 Colorado Street, Suite 3000
Austin, Texas 78701
(512) 457-7000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ (do not check if a small reporting company) | Smaller reporting company | ☒ | ||||||||
Emerging growth company | ☒ | ||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Exchange Act. ☐
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 (File No. 333- 279282), filed with the U.S. Securities and Exchange Commission (the “Commission”) on May 9, 2024 (the “Form S-8”), is being filed by Silvaco Group, Inc. (the “Company” or the “Registrant”) to correct a typographical errors in Exhibit 99.3 and Exhibit 5.1 of the Form S-8 (together, the “Typographical Errors”). Except as revised to correct the Typographical Errors in Exhibit 99.3 and Exhibit 5.1, this Post-Effective Amendment No. 1 to the Form S-8 does not modify or update the previously filed Form S-8. The corrected Exhibits 99.3 and 5.1 are filed herewith as Exhibit 99.3 and Exhibit 5.1, respectively. No additional securities are to be registered, and registration fees were paid upon filing of the original Form S-8.
PART II
Information Required in the Registration Statement
Item 8. Exhibits
| Exhibit Number | Exhibit Description | |||||||
| 4.1 | ||||||||
| 4.2 | ||||||||
| 4.3 | ||||||||
| 4.4 | ||||||||
| 4.5 | ||||||||
| 5.1* | ||||||||
| 23.1** | ||||||||
| 23.2* | ||||||||
| 24.1** | ||||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 99.3* | ||||||||
| 107** | ||||||||
________________
* Filed herewith.
** Previously filed.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Clara, State of California on July 29, 2024.
| SILVACO GROUP, INC. | ||||||||
By: | /s/ Dr. Babak A. Taheri | |||||||
| Name: Dr. Babak A. Taheri | ||||||||
| Title: Chief Executive Officer | ||||||||
| Signature | Title | Date | ||||||||||||
| /s/ Dr. Babak A. Taheri | Chief Executive Officer, and Director (Principal Executive Officer) | July 29, 2024 | ||||||||||||
| Dr. Babak A. Taheri | ||||||||||||||
| /s/ Ryan Benton | Chief Financial Officer (Principal Financial and Accounting Officer) | July 29, 2024 | ||||||||||||
| Ryan Benton | ||||||||||||||
| * | Chair of the Board | July 29, 2024 | ||||||||||||
| Katherine S. Ngai-Pesic | ||||||||||||||
| * | Lead Independent Director | July 29, 2024 | ||||||||||||
Dr. Hau L. Lee | ||||||||||||||
| * | Director | July 29, 2024 | ||||||||||||
| Anita Ganti | ||||||||||||||
| * | Director | July 29, 2024 | ||||||||||||
| William H. Molloie Jr. | ||||||||||||||
| * | Director | July 29, 2024 | ||||||||||||
| Anthony K. K. Ngai | ||||||||||||||
| * | Director | July 29, 2024 | ||||||||||||
| Dr. Walden C. Rhines | ||||||||||||||
| * | Director | July 29, 2024 | ||||||||||||
| Jodi L. Shelton | ||||||||||||||
| *By: /s/ Ryan Benton | ||||||||||||||
| Ryan Benton | ||||||||||||||
| Attorney-in-Fact | ||||||||||||||